Is Emerson Electric Stock Underperforming the S&P 500?

Barchart Barchart Öffnen unter Barchart
Is Emerson Electric Stock Underperforming the S&P 500?

Saint Louis, Missouri-based Emerson Electric Co. (EMR) is a technology and software company that provides various solutions in the Americas and internationally. Valued at a market cap of $79.6 billion, the company operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments. 

Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” EMR fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the specialty industrial machinery industry.  

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

Despite its strength, EMR stock slipped 14.7% from its 52-week high of $165.15, reached on Feb. 11. The stock is down 3.9% over the past three months, underperforming the S&P 500 Index’s ($SPX10.8% rise during the same time frame. 

www.barchart.com

Moreover, EMR has lagged behind the broader market over the longer term. The stock has grown 17% over the past 52 weeks, while SPX delivered 26.5% returns over the same time frame.     

EMR has been trading above its 200-day and 50-day moving averages since the end of May. 

www.barchart.com  

On May 5, EMR stock rose 6.9% following the release of its mixed Q2 2026 earnings. The company’s revenue for the period amounted to $4.6 billion, missing Street’s estimates. However, its adjusted EPS for the quarter came in at $1.54, matching Wall Street’s forecasts. For the current quarter ending in June, Emerson Electric expects per-share earnings to range from $1.65 to $1.70, and for the full year, it expects earnings to range from $6.45 to $6.55 per share. 

When stacked against its peer, Cummins Inc. (CMI), EMR has lagged behind. Over the past year, CMI stock has surged 110.3%.     

Wall Street is taking a moderately optimistic stance on EMR. Among the 25 analysts covering the stock, the overall consensus rating is a “Moderate Buy.” Its mean price target of $165.04 suggests 17.1% rebound potential from current price levels.


On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Dear Dividend Investors, Mark Your Calendars for June 23 Circle Stock Slips as Stripe, Visa, Mastercard Explore Stablecoin Platform Nvidia’s Jensen Huang Says Marvell Is the ‘Next Trillion-Dollar Company.’ Don’t Hold Your Breath. Why the SpaceX IPO Is Sending AT&T Stock Down Today